Related Experiment Video
Updated: Jul 14, 2026

COVID-19 Seroprevalence Test for IgG Antibody Levels Among Healthy Donors Across Different Pandemic Phases in Jeddah
Published on: June 24, 2025
Prevalence of antibodies to hepatitis C virus in blood donors in Riyadh
M Al-Mofarreh1, Y M Fakunle, W M El-Karamany
1Departments of Medicine, and Central Laboratory and Blood Bank, Riyadh Central Hospital, Riyadh, Saudi Arabia.
Abstract:
Prevalence of antibodies to hepatitis C virus (anti-HCV) was determined in 580 voluntary blood donors in Riyadh. Among 403 Saudis screened, the prevalence was 1.24%, while among 177 expatriates screened the prevalence was 4.52%. The difference was statistically significant (P<0.02; x(2)test). The overall prevalence of 2.24% is lower than that reported in Spain (7.3%) but higher than reports from the United Kingdom (0.5 to 1%0, Italy (0.87%), or Germany (0.24 to 0.79%0. In view of reports that blood positive for anti-HCV can transmit non-A, non-B hepatitis, it is advisable to routinely screen donor blood for anti-HCV.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
